Gyeongnam Pharmaceutical, Active Community... Stock Price -6.46%.

At this time, posts about Gyeongnam Pharmaceutical are rapidly increasing on portals and securities communities. Today, foreigners have tentatively been recorded as net buyers of 4,000 shares of Gyeongnam Pharmaceutical, while institutions have been net sellers of 125,000 shares. Gyeongnam Pharmaceutical is known as a pharmaceutical company specializing in products such as Lemona.

As of 1:30 PM on the 13th, Gyeongnam Pharmaceutical's stock price is 8,260 KRW, down 6.46% from the previous day, with a trading volume of 1,664,106 shares, which is about 81.43% of the 5-day average trading volume. On January 12, Gyeongnam Pharmaceutical became a market issue with the news of its rise as the "leader of cold chain-related stocks."

In addition to Gyeongnam Pharmaceutical, posts by investors are also rapidly increasing regarding Dongshin Construction (025950), F&F (007700), and L&K Bio (156100).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.